Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
820.55
-20.95 (-2.49%)
At close: Sep 12, 2025

Remus Pharmaceuticals Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
Operating Revenue
6,2042,125450.27247.17184.18
Upgrade
Other Revenue
-3.591.05-3.9
Upgrade
6,2042,129451.32247.17188.08
Upgrade
Revenue Growth (YoY)
191.44%371.63%82.59%31.42%51.44%
Upgrade
Cost of Revenue
5,3291,644214.69122.81115.04
Upgrade
Gross Profit
874.9484.2236.63124.3673.04
Upgrade
Selling, General & Admin
131.174.2354.734.2429.95
Upgrade
Other Operating Expenses
286.9121.3570.4546.3229.71
Upgrade
Operating Expenses
436.7204.54129.9282.161.41
Upgrade
Operating Income
438.2279.65106.7142.2611.63
Upgrade
Interest Expense
-14.6-4.49-2.04-0.78-0.29
Upgrade
Interest & Investment Income
-22.553.482.450.69
Upgrade
Currency Exchange Gain (Loss)
-5.736.242.220.53
Upgrade
Other Non Operating Income (Expenses)
49.8-0.26-0.26-0.09-0.06
Upgrade
EBT Excluding Unusual Items
473.4303.19114.1446.0612.5
Upgrade
Gain (Loss) on Sale of Investments
---0.081.08
Upgrade
Gain (Loss) on Sale of Assets
-15.1---
Upgrade
Pretax Income
473.4318.29114.1446.1313.58
Upgrade
Income Tax Expense
89.258.5229.1111.793.32
Upgrade
Earnings From Continuing Operations
384.2259.7785.0334.3410.26
Upgrade
Minority Interest in Earnings
-93.5-44.4---
Upgrade
Net Income
290.7215.3785.0334.3410.26
Upgrade
Net Income to Common
290.7215.3785.0334.3410.26
Upgrade
Net Income Growth
34.98%153.29%147.60%234.77%26.39%
Upgrade
Shares Outstanding (Basic)
911888
Upgrade
Shares Outstanding (Diluted)
911888
Upgrade
Shares Change (YoY)
-21.35%38.79%2.10%--
Upgrade
EPS (Basic)
32.6119.0010.414.291.28
Upgrade
EPS (Diluted)
32.6119.0010.414.291.28
Upgrade
EPS Growth
71.62%82.51%142.51%234.77%26.39%
Upgrade
Free Cash Flow
-41.429.6725.8149.6727.72
Upgrade
Free Cash Flow Per Share
-4.642.623.166.213.46
Upgrade
Dividend Per Share
0.7500.7500.250--
Upgrade
Dividend Growth
-200.00%---
Upgrade
Gross Margin
14.10%22.75%52.43%50.31%38.83%
Upgrade
Operating Margin
7.06%13.14%23.64%17.10%6.18%
Upgrade
Profit Margin
4.69%10.12%18.84%13.89%5.45%
Upgrade
Free Cash Flow Margin
-0.67%1.39%5.72%20.09%14.74%
Upgrade
EBITDA
456.9288.39111.3643.8113.38
Upgrade
EBITDA Margin
7.36%13.55%24.67%17.72%7.11%
Upgrade
D&A For EBITDA
18.78.734.641.551.75
Upgrade
EBIT
438.2279.65106.7142.2611.63
Upgrade
EBIT Margin
7.06%13.14%23.64%17.10%6.18%
Upgrade
Effective Tax Rate
18.84%18.39%25.50%25.56%24.47%
Upgrade
Revenue as Reported
6,2532,179466.05254.37192.25
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.